Literature DB >> 1527441

Non invasive estimation of mean right atrial pressure utilizing the 2D-Echo transverse diameter of the left hepatic vein.

L Luca1, P Mario, B Giansiro, F Maurizio, M Antonio, M Carlo.   

Abstract

Aim of our study was to assess if the 2D-Echo transverse diameter of the left hepatic vein (LHV) obtained from the subcostal approach is correlated with invasive mean right atrial pressure (RAP). Thirty-two consecutive patients with acute myocardial infarction were studied by simultaneous 2D-Echo and right heart catheterization. LHV could be adequately imaged in 90% of patients. Mean RAP values at catheterization ranged from 0 to 15 mmHg (mean 6 +/- 3.5 mmHg). A correlation was found between mean RAP and LHV diameter calculated after inspiration (r = 0.81, SEE = 1.54 mm, slope = 0.71, p less than 0.001) as well as after expiration (r = 0.82, SEE = 1.32 mm, slope = 0.62, p less than 0.001) or during post-expiratory apnoea (r = 0.85, SEE = 1.3 mm, slope = 0.71, p less than 0.001). Moreover, percent increments of LHV diameter correlated well with percent changes of mean RAP during rapid infusion of 250-500 cc of saline in 4 patients (r = 0.98, p less than 0.001). Thus, the 2D-Echo LHV diameter is a feasible measurement that seems to correlate well with invasive mean RAP over a wide range of mean RAP values in patients with myocardial infarction; the changes in LHV diameter correlate well with the percent increase in central venous pressure obtained with saline infusion. Underestimation of invasive RAP occurs when mean RAP value exceeds 12 mmHg and can be explained by limited venous compliance. However these preliminary results suggest that this method may represent a valid alternative to obtain a non invasive estimate of mean RAP with 2D-Echocardiography.

Entities:  

Mesh:

Year:  1992        PMID: 1527441     DOI: 10.1007/bf01146837

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  6 in total

1.  Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava.

Authors:  B J Kircher; R B Himelman; N B Schiller
Journal:  Am J Cardiol       Date:  1990-08-15       Impact factor: 2.778

2.  Evaluation of size and dynamics of the inferior vena cava as an index of right-sided cardiac function.

Authors:  F L Moreno; A D Hagan; J R Holmen; T A Pryor; R D Strickland; C H Castle
Journal:  Am J Cardiol       Date:  1984-02-01       Impact factor: 2.778

3.  Echocardiographic assessment of the inferior vena cava wall motion for studies of right heart dynamics and function.

Authors:  G Gullace; M T Savoia
Journal:  Clin Cardiol       Date:  1984-07       Impact factor: 2.882

4.  Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation.

Authors:  P G Yock; R L Popp
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

5.  Effects of positional changes on inferior vena caval size and dynamics and correlations with right-sided cardiac pressure.

Authors:  S Nakao; P C Come; R G McKay; B J Ransil
Journal:  Am J Cardiol       Date:  1987-01-01       Impact factor: 2.778

6.  Real-time inferior vena caval ultrasonography: normal and abnormal findings and its use in assessing right-heart function.

Authors:  G S Mintz; M N Kotler; W R Parry; A S Iskandrian; S A Kane
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

  6 in total
  2 in total

1.  Right ventricular diastolic abnormalities in systemic sclerosis. Relation to left ventricular involvement and pulmonary hypertension.

Authors:  A Giunta; E Tirri; S Maione; S Cangianiello; A Mele; A De Luca; G Valentini
Journal:  Ann Rheum Dis       Date:  2000-02       Impact factor: 19.103

2.  Estimation of Right Atrial Pressure from the Inspiratory Collapse of the Inferior Vena cava in Pediatric Patients.

Authors:  Hamid Amoozgar; Khobiar Zare; Gholamhossein Ajami; Mohammad Borzoee; Saeed Abtahi
Journal:  Iran J Pediatr       Date:  2010-06       Impact factor: 0.364

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.